Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Thomas Moehler

Thomas Moehler

IQVIA, Germany

Danielle Maracaja

Danielle Maracaja

Wake Forest School of Medicine, USA

Recommended Global Hematology Webinars & Conferences

Asia Pacific & Middle East

Blood Disorders 2021

About Conference


Conference Series LLC Ltd welcomes everyone throughout the world to “17th Global Summit on Hematology and Infectious Diseases” which is going to be held in   March 22-23, 2021 in London, UK

Theme: Exploring recent outbreaks, advances & technologies in treatment & research of Infectious Diseases during COVID-19

 After the productive venture of series of hematology conferences around the globe Conference Series LLC Ltd is overwhelmed to welcome all the participants to CME Accredited “17th Global Blood Summit on Hematology and Infectious Diseases” will be held on March 22-23, 2020 at London, UK. The CME Accredited conference is going to be organized round the theme "Exploring recent outbreaks, advances & technologies in treatment & research of Infectious Diseases” which incorporates prompt Keynote presentations, Oral talks, Poster displays and Exhibitions. CME Accredited Hematology and Infectious Diseases 2021 is seventeenth conference that is a global platform to discuss and learn about Hematology, COVID-19, Malaria, Microbial Diseases, Blood Disorders, Hematologic Oncology, Hematologic Disorders, Immunohematology, Blood Disorders: Diagnosis & Treatment, Clinical and Experimental Hematology, Hematopathology, Pediatric hematology, Hematology Nursing, Stem Cell Research and much more.

Hematology  is the discipline concerned with the production, functions, bone marrow, and diseases which are related to blood, blood proteins. The main aim of this conference is to bring Hematologists, Medical professors, Immunologists, Pathologists and scientific researchers. Blood Disorders can affect one or more parts of the blood and prevent blood from doing its functions. They may be acute or chronic

World Infectious Diseases 2021 will be organizing webinars by offering virtual platform to all academicians, researchers, industry professional, and scholars. Webinars will be scheduled on wide range of topics and it will be helpful for scientific fraternity to be connected while staying at their preferred place. Join the webinars organized by us and let the world know about your research and innovation. The Infection Control conference hosting presentations from editors of eminent refereed journals, renowned and active investigators and decision makers in the field of infectious diseases, microbiology, immunology, infection control and prevention. World Infectious Diseases 2021 Organizing Committee also invites young investigators at each and every career stage to submit abstracts reporting their latest scientific research in oral and poster sessions.

Scope

Common blood related disorders include Leukemia, Anemia, Bleeding, Clotting and Myeloma. Blood disorders mainly affect blood components such as White blood cells, Red blood cells, and Platelets.

The Infectious Diseases Conference 2021 welcomes all the participants from all over the world to attend the grand conference "Hematology and Infectious Diseases" on March 21-23, 2020 at London UK which incorporates brief keynote introductions, oral talks, blurb introductions and presentations. Teachers, Researchers around the world will grandstand their examination work and will illuminate the way wherein Men, Women and Children of all socioeconomics can be restored of various Infectious Diseases.

As the topic says the recognition behind this meeting is to mindful individuals about the 3C's which are Cause, Complications and Cure of Diseases. The overall passings because of just Infectious Diseases are as per the following:

  1. HIV/AIDS (1 million)
  2. Respiratory Infections (4.4 million)
  3. Diarrhea (3.1 million)
  4. Hepatitis b (1.1million)
  5. Tetanus (500,000)
  6. Measles (1 million)
  7. Malaria (2.1million)
  8. Tuberculosis (3.1 million)

 

As we realize that these are the name rundown of the unmistakable ailments just, there are a few different ailments which will be likely explanations of more passing, if not taken consideration at a beginning period.

 Why to attend?

Infectious Diseases gathering incorporates two days of introduction on techniques and systems which are identified with Control and Prevention of Infectious Diseases just as to investigate new developments and ideas on a worldwide scale. It's a chance to cooperate with the conspicuous personalities in the field of Infectious Diseases and learn.

This gathering will consolidate the feature of momentum advancements in the field of Medical Science in its battle against wellbeing perils. The intelligent sessions with the comprehensively acclaimed speakers will likewise be advantageous for the scholarly understudies from the field of Medical Science to expand their insight in the individual field.

 

Market Analysis

The market size for clinical microbiology valued at USD 9.1 billion in 2016 and is expected to develop at a CAGR of 6.7% over the forecast period. Constantly rising of infectious diseases is driving market growth.
 
Infectious diseases are primarily diagnosed by using clinical tests. According to the Centres for Disease Control and Prevention (CDC), around 9,421 new cases of tuberculosis, 51,455 new cases of salmonella, 33,461 new cases of Lyme disease, and in 2014, 433 new cases of meningococcal disease were registered in U.S.
 
According to the American Cancer Society, 1,688,780 new cases of cancer were diagnosed in U.S. in 2017. Clinical tests are made as one of the major diagnostic tools is expected to augment market growth in future. Sudden outbreaks of Ebola, Zika, and other contagious diseases are also contributing to rising prevalence of infectious diseases.
 
 
Conference Image
 
Product Insights
 
Reagents accounted for the global revenue share in the clinical microbiology market. This segment includes products such as solutions, primers, master mixes, and kits used in various diagnostic assays. Reagents currently takes the largest revenue share, with more than 60% attributed to repeat purchase driven by need for new set of reagents for new tests.
 
This segment is expected to remain dominant throughout the forecast period. Factors such as higher cost of specialized kits and constant repeat purchase are expected to drive the segment over the forecast period. The market is witnessing rising investments in research and development (R&D). Almost all analytical and therapeutic research projects demand reagents and chemicals, thereby driving penetration of reagents.
 
 

Conference Image

Session and Tracks

Track 01: Corona Virus Diseases

Coronavirus is a provisional name given to coronaviruses of medical significance before a permanent name is decided upon. Although coronaviruses are endemic in humans and infections normally mild, such as the common cold (caused by human coronaviruses in ~15% of cases), cross-species transmission has produced some unusually virulent strains which can cause viral pneumonia and in serious cases even acute respiratory distress syndrome and death.
 
 

Track 02: Bacterial Infectious Diseases

Bacteria common noun bacteria, singular bacterium is a type of biological cell. They constitute a large domain of prokaryotic microorganisms. Typically, a few micrometers in length, bacteria have several shapes, ranging from spheres to rods and spirals. Bacteria were among the first life forms to appear on Earth and are present in most of its habitats. Bacteria inhabit soil, water, acidic hot springs, radioactive waste, and the deep biosphere of the earth's crust. Bacteria also live in symbiotic and parasitic relationships with plants and animals.
 

Track 03: Antigen-antibody reactions

Antigen-antibody interaction, or antigen-antibody reaction, is a specific chemical interaction between antibodies produced by B cells of the white blood cells and antigens during immune reaction. The antigens and antibodies combine by a process called agglutination. It is the fundamental reaction in the body by which the body is protected from complex foreign molecules, such as pathogens and their chemical toxins. In the blood, the antigens are specifically and with high affinity bound by antibodies to form an antigen-antibody complex. The immune complex is then transported to cellular systems where it can be destroyed or deactivated.
 

Track 04: Reproductive infectious diseases

Reproductive tract infection (RTI) are infections that affect the reproductive tract, which is part of the Reproductive System. For females, reproductive tract infections can affect the upper reproductive tract (fallopian tubes, ovary and uterus) and the lower reproductive tract (vagina, cervix and vulva); for males these infections affect the penis, testicles, urethra or the vas deferens. The three types of reproductive tract infections are endogenous infections, iatrogenic infections and the more commonly known sexually transmitted infections. Each has its own specific causes and symptoms, caused by a bacterium, virus, fungus or other organism. Some infections are easily treatable and can be cured, some are more difficult, and some are non curable such as AIDS and herpes.
 

Track 05: Mycobacterial infections

Mycobacterium is a genus of Actinobacteria, given its own family, the Mycobactericidal. Over 190 species are recognized in this genus. This genus includes pathogens known to cause serious diseases in mammals, including tuberculosis (Mycobacterium tuberculosis) and leprosy (Mycobacterium leprae) in humans. The Greek prefix myco- means "fungus," alluding to the way mycobacteria have been observed to grow in a mold-like fashion on the surface of cultures. It is acid fast and cannot be stained by the Gram stain procedure.
 

Track 06: Aspects of plant bacteriology

Plant pathology (also phytopathology) is the scientific study of diseases in plants caused by pathogens (infectious organisms) and environmental conditions (physiological factors). Organisms that cause infectious disease include fungi, oomycetes, bacteria, viruses, viroid’s, virus-like organisms, phytoplasmas, protozoa, nematodes and parasitic plants. Not included are ectoparasites like insects, mites, vertebrate, or other pests that affect plant health by eating of plant tissues. Plant pathology also involves the study of pathogen identification, disease etiology, disease cycles, economic impact, plant disease epidemiology, plant disease resistance.
 

Track 07: Pathogenic infections

In biology, a pathogen in the oldest and broadest sense, is anything that can produce disease. A pathogen may also be referred to as an infectious agent, or simply a germ. The term pathogen came into use in the 1880s. Typically, the term is used to describe an infectious microorganism or agent, such as a virus, bacterium, protozoan, prion, viroid, or fungus. Small animals, such as certain kinds of worms and insect larvae, can also produce disease. However, these animals are usually, in common parlance, referred to as parasites rather than pathogens.
 

Track 08: Sexually transmitted diseases

Human Immunodeficiency Virus damages the immune system. The Untreated HIV contaminates and damages CD4 cells. Thereafter HIV kills more and more CD4 cells, due to which body is bound to get different sorts of diseases and malignant growths. HIV is generally transmitted through organic liquids that incorporates blood, breast milk, semen, vaginal and rectal liquids. The infection generally doesn't spread through air, water or through easy-going contact. HIV is a lifelong condition and right now there is no cure for this severe disease. Without treatment, a man with HIV is probably going to build up a serious condition called AIDS.
 

Track 09: Animal vaccination

Animal vaccination is the immunization of a domestic, livestock or wild animal. The practice is connected to veterinary medicine. The first animal vaccine invented was for chicken cholera in 1879 by Louis Pasteur. The production of vaccines for animals and humans has always been linked, this relationship has been coined 'One Health', as at least 61% of all human pathogens originate from animals. Two main examples of this link are the rabies and smallpox vaccines. The production of such vaccines encounter issues in relation to the economic difficulties of individuals, the government and companies.
 

Track 10: Respiratory infectious diseases

The upper respiratory tract is generally considered to be the airway above the glottis or vocal cords, sometimes it is taken as the tract above the cricoid cartilage. This part of the tract includes the nose, sinuses, pharynx, and larynx. Typical infections of the upper respiratory tract include tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, certain types of influenza, and the common cold. Symptoms of URIs can include cough, sore throat, runny nose, nasal congestion, headache, low grade fever, facial pressure and sneezing.
 

Track 11: Lower respiratory tract infection 

Lower respiratory tract infection(LRTI) is a term often used as a synonym for pneumonia but can also be applied to other types of infection including lung abscess and acute bronchitis. Symptoms include shortness of breath, weakness, fever, coughing and fatigue. A routine chest X-ray is not always necessary for people who have symptoms of a lower respiratory tract infection. Influenza affects both the upper and lower respiratory tracts Antibiotics are the first line treatment for pneumonia; however, they are neither effective nor indicated for parasitic or viral infections. Acute bronchitis typically resolves on its own with time.
 

Track 12: Chickenpox

Chickenpox, also known as varicella, is a highly contagious disease caused by the initial infection with varicella zoster virus (VZV). The disease results in a characteristic skin rash that forms small, itchy blisters, which eventually scab over. It usually starts on the chest, back, and face. It then spreads to the rest of the body. Other symptoms may include fever, tiredness, and headaches. Symptoms usually last five to seven days. Complications may occasionally include pneumonia, inflammation of the brain, and bacterial skin infections.
 

Track 13: Malaria vaccines

A malaria vaccine is a vaccine that is used to prevent malaria. The only approved vaccine as of 2015 is RTS,S, known by the trade name Mosquirix. It requires four injections, and has a relatively low efficacy. Due to this low efficacy, the World Health Organization (WHO) does not recommend the routine use of the RTS,S vaccine in babies between 6 and 12 weeks of age.A WHO-led implementation program is piloting the vaccine in three high-malaria countries in Africa in 2019. The first phase of the project, covered by grants from Unit aid, Gavi and the Global Fund, is planned to establish the feasibility, impact and safety of RTS, S, when used as part of a routine immunization program. Research continues into recombinant protein, attenuated whole organism and viral vectored vaccines.
 

Track 14: Ebola and zika infections

Zika virus (ZIKV) is a member of the virus family Flaviviridae. It is spread by daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus. The infection, known as Zika fever or Zika virus disease, often causes no or only mild symptoms, similar to a very mild form of dengue fever. bola, also known as Ebola virus disease (EVD), is a viral haemorrhagic fever of humans and other primates caused by ebolaviruses. Signs and symptoms typically start between two days and three weeks after contracting the virus with a fever, sore throat, muscular pain, and headaches.
 

Track 15: Viral infectious diseases

A viral disease (or viral infection, or infectious disease) occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles (virions) attach to and enter susceptible cells Double-stranded DNA families: three are non-enveloped (Adenoviridae, and Polyomaviridae) and two are enveloped (Herpesviridae and Poxviridae). All of the non-enveloped families have icosahedral capsids. Partly double-stranded DNA viruses: Hepadnaviridae. These viruses are enveloped.
 

Track 16: Microbiological infectious diseases

Medical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.
 

Track 17: Epidemiology

Epidemiology is the study and analysis of the distribution (who, when, and where), patterns and determinants of health and disease conditions in defined populations. It is a cornerstone of public health, and shapes policy decisions and evidence-based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, collection, and statistical analysis of data, amend interpretation and dissemination of results (including peer review and occasional systematic review).
 

Track 18: Food infections

Foodborne illness is an infection or irritation of the gastrointestinal (GI) tract caused by food or beverages that contain harmful bacteria, parasites, viruses, or chemicals. Common foodborne illness symptoms include vomiting, diarrhea, abdominal pain, fever, and chills.
 

Track 19: Diagnosis and treatment

Diagnosis is the identification of the nature and cause of a certain phenomenon. Diagnosis is used in many different disciplines, with variations in the use of logic, analytics, and experience, to determine "cause and effect". In systems engineering and computer science, it is typically used to determine the causes of symptoms, mitigations, and solutions. It is the process of determining which disease or condition explains a person's symptoms and signs. It is most often referred to as diagnosis with the medical context being implicit.
 

Track 20: Tuberculosis

Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs but can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those affected. The classic symptoms of active TB are a chronic cough with blood-containing mucus, fever, night sweats, and weight loss.
 

Track 21: Blood and Hematology

The word Heme came from Greek which means blood. Hematology involves the diagnosis and treatment of patients who have disorders of the blood and bone marrow. It is mainly responsible for the diagnosis of benign and malignant disorders of the red and white blood cells, platelets and the coagulation system in adults and children. Blood disorders are conditions that impact the blood's ability to function correctly; their patients may have a serious life- threatening illness such as leukemia, lymphoma or myeloma that requires chemotherapy. 
Physicians who work on treating hematologic disorders, referred to as Hematologists. Hematologists as well hematopathologists both work in conjugation for giving the best therapy.
 

Track 22: Blood disorders

A. Anemia
Anemia is a condition in which you don't have enough healthy red blood cells to carry adequate oxygen to the body's tissues. Having Anemia may make you feel tired and weak. There are many forms of Anemia, each with its own cause. Anemia can be temporary or long term, and it can range from mild to severe.
Sub- tracks: 
1. Iron deficiency and impaired immunity
2. Iron and pathogens
3. Causes of Anemia
4. Risk factors
5. Nutritional Anemia
6. Stages of anemia
 
Myeloma, also known as multiple myeloma, it can be benign and malignant, is a blood cancer arising from plasma cells. At any one time there are around 17,500 people living with myeloma in the UK. It accounts for 15 per cent of blood cancers, and two per cent of all cancers. Myeloma mainly affects those over the age of 65, however it has been diagnosed in people as young as 20.
Sub- tracks: 
1. Multiple Myeloma
2. Signal Transduction
3. Metastatic Cancer
4. Hematologic Cancer
5. Signaling Pathway
6. Information on Drugs
7. Medicine for Inflammation
 
Coagulopathy is a condition in which the blood's ability to coagulate (form clots) is impaired. This condition can cause a tendency toward prolonged or excessive bleeding, which may occur spontaneously or following an injury or medical and dental procedures
Sub- tracks: 
1. Thrombocytopenia
2. Qualitative Platelet Disorders
3. Inherited Thrombocytopenia
4. Vascular Abnormalities
5. Coagulopathy of liver disease
6. drug-induced platelet dysfunction
7. Acquired clotting factor inhibitors
8. Hemophilia A
9. Hemophilia B
 
Leukemia is a cancer which starts in blood-forming tissue, usually the bone marrow. It leads to the over-production of abnormal white blood cells, the part of the immune system which defends the body against infection. 
Sub- tracks: 
1. Oncogene
2. Pancreatic and Colorectal Cancer
3. Gynecologic Oncology
4. Melanoma and Carcinoma
5. Molecular & Cancer Biomarkers
6. Leukemia and Bone marrow Transplantation
7. Neoplasms
8. Biomedical Research
 
Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel. It is the first stage of wound healing. This involves coagulation, blood changing from a liquid to a gel. Intact blood vessels are central to moderating blood's tendency to form clots.
Sub- tracks: 
1. Hemodialysis
2. Thrombotic Thrombocytopenic Purpura
3. Hemodialysis
4. Hemolytic Anemia
 
Thalassemia is a blood disorder passed down through families (inherited) in which the body makes an abnormal form or inadequate amount of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen. The disorder results in large numbers of red blood cells being destroyed, which leads to anemia.
Sub- tracks: 
1. Hemochromatosis.
2. Idiopathic thrombocytopenic purpura.
3. Malaise.
4. Bone marrow transplantation.
5. Blood transfusion.
 
Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV). Typically, this is followed by a prolonged period with no symptoms. As the infection progresses, it interferes more with the immune system, increasing the risk of developing common infections such as tuberculosis, as well as other opportunistic infections, and tumors that rarely affect people who have uncompromised immune systems. These late symptoms of infection are referred to as acquired immunodeficiency syndrome (AIDS). This stage is often also associated with unintended weight loss.
Sub- tracks: 
1. Sexually Transmitted Diseases
2. Immunology and Vaccine development
3. Diagnosis and Treatment
4. Sexual Health
5. Clinical Research and Case Reports
 

Track 23: Diagnosis, Treatment and Management of Blood disorders

There are certain methods for treatment of Blood Disorders. Main treatment for blood disease is named replacement therapy. Researchers are attempting to search out ways that to correct the defective genes that cause Blood Disorders. Gene therapy hasn't nonetheless developed to the purpose that it's accepted treatment for hemophilia. However, researchers still take a look at gene therapy in clinical trials. Bone marrow Transplantation, Hematopoietic stem cell therapy and Cord blood transplantations are new rising varieties of treatment for hemophilia and alternative blood disorders.
Initially for detecting the blood disorders bone marrow biopsy will be carried out which involves the study of cytogenetic and surface proteins on bone marrow cells and this study process referred to be flow cytometry. Treating of blood disorder may vary for every particular disorder, this can include use of coagulation factor support, immune modulating therapies, chemotherapy, and bone marrow transplantation palliative care must be taken for the patients with complex disorder. Generally, through physical examinations, medical reports are used to detect the disorders by physicians to initiate the best therapy. 
Sub- tracks: 
1. Bone marrow transplantation.
2. Malaise.
3. Hemochromatosis.
4. Blood transfusion
5. Idiopathic thrombocytopenic purpura.
 

Track 24:  Blood transfusion

Blood transfusion is the process of receiving whole blood or blood products into one’s systemic circulation intravenously. Blood transfusion is usually done in cases of deficiencies, to increase the oxygen saturation, during accidents or during surgery, to treat hematologic conditions such as severe anemia, leukemia, and sickle cell disease. Transfusion may include injection of whole blood or components such as red blood cells, white blood cells, plasma, platelets or clotting factors. Hence a very systematic protocol is followed for blood transfusion which includes processing and testing the donor’s blood for possible infectious disorders, particularly for viruses such as Hepatitis B and C, HIV, and West Nile Virus. The system should include monitoring, identification, reporting, investigation and analysis of adverse events near-misses and reactions related to transfusion and manufacturing. Research and Development in this area of Hematology is hence considered a very important aspect.
Sub- tracks: 
1. Pulmonary Embolism
2. Graft versus Host disease (GVHD).
3. Sickle cell anemia
4. Blood Disorders
5. Compatibility testing
6. Organ Transplant
7. Disseminated Intravascular Coagulation
 

Track 25: Blood Transplantation, Thrombosis and Hemostasis

The umbilical cord is a conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies the fetus with  nutrient-rich blood from the placenta The hematopoietic bone marrow transplant, the HSC are removed from a large bone of the donor, typically the pelvis, through a large need let that reaches the center of the bone. Acute myeloid leukemia is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells and the Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. The Hemostatic is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing.
 

Track 26: Hematology and neurological disorders

The theme of Hematologic ailment is massive, counting disorders of cellular component extremes, insufficiencies or ruin, and dysfunction. Most of the ailments may lead to neurologic impediment. Some of these conditions are very specific to the hematologic complaint Anemia whereas others are common to numerous circumstances. This session deals with Hematologic and their associated neurologic disorders. 
Sub- tracks: 
1. Thrombocytopenia
2. Sickle Cell Anemia
3. Cerebra Venous Thrombosis
4. Thalassemia with paraplegia
5. Leptomeningeal metastasis
6. Hypercoagubility and ischemic stroke
7. Ovarian Hyperstimulation Syndrome
8. Polyneuropathy associates with leukoencephalopathy
 

Track 27: Hematology-oncology

Hematology-oncology is the science applied to treat blood disorders and diseases like cancers (oncology). Also, it treats with blood cancers and some disease includes iron deficiency anemia, thalassemia’s as well other organ cancers. The treatment will vary for individual suffering with myeloma based on many factors, in this multiple myeloma it includes a stage referred smoldering stage in which it doesn’t show active symptoms that is the state in which myeloma cells present in the body were not progressive.
Sub- tracks: 
1. Acute myelogenous leukaemia.
2. Non-Hodgkin’s lymphomas.
3. Chronic lymphocytic leukaemia.
4. Acute lymphoblastic leukaemia.
5. Acute monocytic leukaemia.
6. Hodgkin’s lymphomas.
 

Track 28: Hematologic Malignancies

Hematology oncology is the most important part of Hematology research, a major part of blood based researches is carried out in this field. Lymphatic leukemic which effect the white blood cells, they are closely related to the lymphomas and some of them are unitary diseases which related to the adult T cells leukemia these come under the lymph proliferative disorders. The cancer which originates from white blood cells are called as lymphoma and this disorder is mainly seen in Hodgkin lymphoma these diseases are treated by radiation and chemotherapy, or hematopoietic stem cell transplantation. The cancer which starts with in the cell is called as Non Hodgkin lymphocytes and these lymphocytes are of lymph nodes. The bone marrow which develops too many white blood cells leads to multiple myeloma. The further details on malignance are been discussed in Hematology oncology conference.    
 

Track 29: Hematology and Pharma Industry

The overall market for the hematological pharmaceuticals in top point as it is as often as possible foreseen to be improved over two or three decades. According to the overall market master, the hematology cure and definite market is depended upon to create at the rate of 7.5% from 2015-2020. A portion of the best drug store enterprises creating Biological Drugs and Generic Drugs fuse. Takeda Oncology, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, AstraZeneca, Merck and Co., Amgen, Janssen bio tech, Pfizer, Bayer, Otsuka, Sanofi, Astellas, Eisai, AbbVie, Pharmacyclics, Merck KGaA and Incyte.
 

Track 30: Stem cell research

Stem cell research deals with research and publication of high quality manuscripts related to stem cells. Stem cells are cells of multicellular organisms that can differentiate into other types of cells. They can divide more cells of the same type of stem cells. For a cell to be considered a stem cell, it should be self-renewing and must be either totipotent or pluripotent. Haemopoietic stem cell transplants are used in the treatment of cancers and other immune system disorders.
Sub- tracks:
1. Stem cell therapy.
2. Different types of stem cells.
3. Stem cell transplantation.
4. Stem cell biomarkers.
5. Stem cell products.
 

Track 31: Myelodysplastic Syndromes

Myelodysplastic disorders are a gathering of diseases in which juvenile platelets in the bone marrow don't develop and in this way don't end up noticeably solid platelets. At an early stage there are ordinarily no indications. Later side effects may incorporate feeling tired, shortness of breath, simple dying, or successive contaminations. A few sorts may form into intense myeloid leukemia.
 
Hazard factors incorporate past chemotherapy or radiation treatment, presentation to specific chemicals, for example, tobacco smoke, pesticides, and benzene, and introduction to substantial metals, for example, mercury or lead. Issues with platelet development result in some mix of low red platelets, low platelets, and low white platelets. A few sorts have an expansion in youthful platelets, called impacts, in the bone marrow or blood. Medicines may incorporate steady care, sedate treatment, and foundational microorganism transplantation.
 

Track 32: Hematologic Therapies

The Center for Hematologic Oncology provides specialized care for all types of cancers of the blood, including leukemia, lymphoma, multiple myeloma, as well as related disorders of the blood, such as aplastic anemia and Myelodysplastic syndrome.
 

Track 33: Biomarkers in Hematology

Protein Biomarkers can be utilized as biomarkers for early location of tumors particularly utilized for the ID of bosom growth. Symptomatic Patients with suspected pancreatic malignancy will experience an underlying CT sweep to decide whether a presume mass is confined and evacuated by surgery 63% of patients will be determined to have non-resectable stage III and IV ailment and a biopsy will be attempted to affirm pancreatic disease by H&E neurotic examination. The Novel Biomarker BI-010 has been distinguished as a very delicate (98%) and particular (95%) IHC marker for pancreatic disease and CRT is looking for an accomplice to build up an IHC based test to recognize BI-010 in fine needle suction biopsies from biopsy tests.
Basically, Biomarkers mainly helpful in following areas:-
Drug Targeting.
Prognosis and treatment production.
Pharmacodynamics and Pharmacokinetics.
Monitoring treatment response.
 

Track 34: Immunohematology

Immunohematology is referred to as blood managing an account also, is a branch of Hematology which contemplates antigen-counter acting agent responses and comparative wonders as they identify with the pathogenesis and clinical indications of blood issue. Individuals working in this field are noted to as an immuno-hematologist. Their standard obligations incorporate cross-coordinating, blood writing and immune response recognizable proof. This region is managing planning blood, blood parts and so on for transfusion and variety of more good segments for blood transfusion. Individuals may be vaccinated to RBCs due to earlier contact to RBCs of different people, as often as possible through pregnancy or transfusion.
 

Track 35: Various Aspects of Hematology

Pediatric Hematology covers all aspects of pediatric hematology and oncology. It includes immunology, pathology, and pharmacology in relation to blood diseases and cancer in children and shows how basic experimental research can contribute to the understanding of clinical problems. Physicians specialized in hematology are known as hematologists or hematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the hematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various hematological test results and blood clotting test results. In some institutions, hematologists also manage the hematology laboratory. Physicians who work in hematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologists or hematopathologists. Experimental Hematology is another important part of blood based research carried out throughout the world.
 

Track 36: Effect of Advanced Technologies on Blood Based Products

A blood substitute is a substance used to mimic and fulfill some functions of biological blood. It aims to provide an alternative to blood transfusion, which is transferring blood or blood-based products from one person into another. Thus far, there are no well-accepted oxygen-carrying blood substitutes, which are the typical objective of a red blood cell transfusion; however, there are widely available non-blood volume expanders for cases where only volume restoration is required. These are helping doctors and surgeons avoid the risks of disease transmission and immune suppression, address the chronic blood donor shortage, and address the concerns of Jehovah's Witnesses and others who have religious objections to receiving transfused blood. Pathogen reduction using riboflavin and UV light is a method by which infectious pathogens in blood for transfusion are inactivated by adding riboflavin and irradiating with UV light. This method reduces the infectious levels of disease-causing agents that may be found in donated blood components, while still maintaining good quality blood components for transfusion. This type of approach to increase blood safety is also known as “pathogen inactivation” in the industry
 

Track 37: Molecular Typing for Blood

Blood group antigens are polymorphic residues of protein or carbohydrate on the red cell surface. They can provoke an antibody response in individuals who lack them, and some antibodies can lead to hemolytic transfusion reaction or hemolytic disease of the fetus/newborn. Researchers have identified the molecular basis of many red cell blood group antigens, and an actively maintained database currently lists over 1,600 alleles of 44 genes. This mini-review describes the major applications of the explosion of knowledge in blood group genetics to the practice of blood banking and transfusion medicine.
Transfused patients: Typing of multiply transfused patients, where serological testing cannot be used because of the presence of transfused red cells.
Immunoglobulin-coated red cells: Typing of red cells giving a positive direct anti-globulin test (DAT), usually in patients with autoimmune hemolytic anemia, to help in the identification of underlying alloantibodies.
Determining Rh variants: Molecular methods are used for identifying Rh variants, especially the weak and partial variants of D, to assist in the provision of the most suitable blood for transfusion.
Confirmation of D negative: Detection of RHD in an apparently D negative donor could signal very weak D expression, which could immunize a D negative patient. 
 

Track 38: Bone Marrow Transplantation and Surgery

Bone Marrow Transplantation: A bone marrow transplant, otherwise called a Haemopoietic immature microorganism transplant, replaces harmed bone marrow with sound bone marrow undeveloped cells. Bone marrow is an elastic tissue found in the empty focuses of a few bones. It contains master undifferentiated organisms, which create the body's platelets.
A biopsy is an example of tissue taken from the body with a specific end goal to look at it all the more intently. A specialist ought to prescribe a biopsy when an underlying test recommends that a territory of tissue in the body isn't typical. Specialists may call that zone of unusual tissue an injury, a tumor, or a mass. Subjects of talk in the logical sessions are Bone Marrow Surgery, Stem Cell Surgery, and Hematopoietic Cell Transplantations.
 

Track 39:  Clinical and Experimental Hematology

Clinical and Experimental Medicine publishes reports of clinical and experimental work concerned with the following fields: clinical chemistry, hematology, immunology, oncology and virology. The major criteria for publication will be clarity, experimental soundness and advances in knowledge. Papers containing new clinical or experimental data, are likely to contribute to changes in clinical practice in thinking about a disease will be given priority due to their immediate importance.
 

Track 40: New Drug Discovery in Hematology

Advancing novel therapeutic agents for the treatment of malignancy into the marketplace is an increasingly costly and lengthy process. Patients sometimes given as a pill, and that they facilitate keep blood clots from breaking down. These medicines most frequently are used before dental work or to treat bleeding from the mouth or nose or gentle intestinal bleeding. Some semisynthetic hormones are accustomed treat people that have gentle hemophilia A. Currently pharmaceutical firms are involved in the main specializing in Recombinant, genetically engineered pharmaceuticals which may be smart alternative for treatment. If you have got a gentle form of hemophilia, a medicine referred to as desmopressin acetate (DDAVP) will briefly increase the concentration of factor VIII in your blood. DDAVP may be given intravenously, through an injection, or within the type of nasal spray. Antifibrinolytic medicines like tranexamic acid and epsilon aminocaproic acid are that are typically used with replacement therapy to assist keep blood clots from breaking down. 
Finally, the mechanisms to enhance drug repurposing through increased collaborations between academia, industry, and non-profit charitable organizations are discussed.
Sub- tracks: 
1. Hematopoietic Cells Mobilization
2. Patient-reported outcomes in drug development
3. De novo drug discovery
4. Clinical trials
5. Future directions and conclusions 
 

Track 41: New Drug Discovery in Hematology

Advancing novel therapeutic agents for the treatment of malignancy into the marketplace is an increasingly costly and lengthy process. As such, new strategies for drug discovery are needed. Drug repurposing represents an opportunity to rapidly advance new therapeutic strategies into clinical trials at a relatively low cost. Known on-patent or off-patent drugs with unrecognized anticancer activity can be rapidly advanced into clinical testing for this new indication by leveraging their known pharmacology, pharmacokinetics, and toxicology. Using this approach, academic groups can participate in the drug discovery field and smaller biotechnology companies can “de-risk” early-stage drug discovery projects. Here, several scientific approaches used to identify drug repurposing opportunities are highlighted, with a focus on hematologic malignancies. In addition, a discussion of the regulatory issues that are unique to drug repurposing and how they impact developing old drugs for new indications is included. Finally, the mechanisms to enhance drug repurposing through increased collaborations between academia, industry, and non-profit charitable organizations are discussed.
•        Non-Hodgkin Lymphoma
•        Hematopoietic Cells Mobilization
•        Multiple myeloma
•        Patient-reported outcomes in drug development
•        De novo drug discovery
•        Drug Repurposing
•        Population outcomes
•        Clinical trials
•        Future directions and conclusions
 

Track 42: Case reports and epidemiology of Hematology & Hem- Oncology

Case Reports in Hematology is a peer-reviewed, Open Access journal that publishes case reports and case series in all areas of hematology, including general hematology, pathology, and oncology, with a specific focus on lymphomas and leukemia.
Case Reports in Hematology is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as via the LOCKSS initiative. It operates a fully open access publishing model which allows open global access to its published content. This model is supported through Article Processing Charges.
 

Track 43:  Entrepreneurs Investment Meet

 Hematology and Blood Disorder 2019 aims to bring all existing and budding entrepreneurs to share experiences and present new innovations and challenges in Blood disorder community. Each year, over a million companies are started in the world with about 5-10 of them classified as high technology companies. Turning ideas into business is tricky and the opportunity recognition is the most important stage for establishment of new venture. This two day event will showcase talks, posters from renowned speakers addressing all the new challenges and advancement in the field of Hemophilia and Blood disorder. This session will include cutting edge Blood disorder research to highlight the advancement in the medical field.
 

Abstract Deadlines

Deadlines
 
1st Round of abstract submission:  October  25, 2020
 
2nd Round of abstract submission:  December 25, 2020
 
3rd Round of abstract submission:  February 25, 2021
 
Avail early bird registration benefits on or before : December 18, 2020
 
Avail group participation discounts on more than 5 participants.

Participation and Benefits

PARTICIPATION OPTIONS: World Infectious Diseases 2021, provides the participants with different modes or ways to participate under either ACADEMIC / STUDENT / BUSINESS Category
 
  • Keynote speaker: 45-50 minutes:
  • Speaker (oral presentation): 25-30 minutes (only one person can present)
  • Speaker (workshop): 45-50 minutes (more than 1 can present)
  • Speaker (special session): 45-50 minutes (more than 1 can present)
  • Speaker (symposium): more than 45 minutes (more than 1 can present)
  • Delegate(only registration): will have access to all the sessions with all the benefits of registration
  • Poster presenter:  can present a poster and enjoy the benefits of delegate
  • Remote attendance:  can participate via video presentation or e-poster presentation
  • Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
  • Media partner
  • Sponsor
  • Collaborator
 
For more details about each mode, kindly contact: [email protected]
WhatsApp office: +44-7723554286
 
PARTICIPATION BENEFITS:
  • This Live conference is accredited with CPD credits.
  • Attend Keynote Presentation by world’s most eminent researchers
  • Access to all the sessions
  • Get OCM certificate
  • Get worldwide acknowledgment to your profile and Research
  • Get your abstracts published with unique DOI in International Journals
  • Get up to 50% discounts for publishing your entire article in our open access International Journals
  • Get Handbooks and conference kits
  • Get an access to the network with eminent personalities from worldwide

Past Conference Report

World Infectious Diseases 2020

 
We had successfully hosted the “16th Global Summit on Hematology and Infectious Diseases” during March 02-03, 2020 at London, UK. The conference was successful in bringing together renowned speakers from various reputed organizations and their paramount talks enlightened the gathering.
 
Keynote Speakers:
  1. Victor Lage de Araujo, CAP Evidence-UK
  2. Thomas Moehler, IQVIA, Germany
  3. Dr Maha El Taweel, Egypt

Infectious Diseases Meet 2019

We had successfully hosted the “15th Global Summit on Hematology and Infectious Diseases” during February 27-28, 2019 at Tokyo, Japan. The conference was successful in bringing together renowned speakers from various reputed organizations and their paramount talks enlightened the gathering.
The pragmatic meet organized by our management received generous response from the academia, talented Keynote Speakers, Speakers, Young Researchers, Students & Business Delegates who attended from different parts of the world made their valuable contribution to make it a successful event. The conference was marked with the presence of eminent Speakers, Young Researchers, Students & Business Delegates driving the event into the path of success with thought provoking keynote& plenary presentations.
 
The Conference focused on recent developments in the field of Infectious Diseases and the meeting engrossed in knowledgeable discussions on Novel Subjects.
 
Special Session:
 
Title: Is it possible to treat community-acquired and nosocomial infections with the same method
without the use of antibiotics
 
Huang Wei Ling, Medical Acupuncture and Pain Management Clinic, Brazil
 
Title: Why are diabetic patients still having hyperglycemia despite diet regulation, antiglycemic medication and insulin
 
Huang Wei Ling, Medical Acupuncture and Pain Management Clinic, Brazil
 
The proceedings of the conference were embarked with an opening ceremony followed by Special sessions and a series of Lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talks were:
 
Keynote forum:
 
Yoshinori Hayakawa, Toin University of Yokohama, Japan
Huang Wei Ling, Medical Acupuncture and Pain Management Clinic, Brazil 
We extend our heartiest thanks to all the Organizing Committee Members for their kind support rendered towards the success of Infectious Diseases Meet 2019. At the same time we take the opportunity to thank all the speakers, delegates and participants for providing their valuable contribution and time for Infectious Diseases Meet 2019.
 
Apt Carol, South Carolina State University, USA
Yoshinori Hayakawa, Toin University of Yokohama, Japan
Huang Wei Ling, Medical Acupuncture and Pain Management Clinic, Brazil 
Xavier Fernàndez-Busquets, Institute for Bioengineering of Catalonia, Spain
In-Woo Park, University of North Texas Health Science Centre, USA
Infectious Diseases  Meet 2019 Organizing Committee would like to thank the Moderator of the conference, Dr. Sovann Peng, who contributed a lot for the smooth functioning of this event.
 
 

Infectious Diseases Meet 2018 Report:

We had successfully hosted the “Global Experts Meeting on Infectious Diseases” during September 03-04, 2018 at Tokyo, Japan. The conference was successful in bringing together renowned speakers from various reputed organizations and their paramount talks enlightened the gathering.
 
The pragmatic meet organized by our management received generous response from the academia, talented Keynote Speakers, Speakers, Young Researchers, Students & Business Delegates who attended from different parts of the world made their valuable contribution to make it a successful event. The conference was marked with the presence of eminent Speakers, Young Researchers, Students & Business Delegates driving the event into the path of success with thought provoking keynote& plenary presentations.
 
The Conference focused on recent developments in the field of Infectious Diseases and the meeting engrossed in knowledgeable discussions on novel subjects.
 
Special Session:
 
Title: Mathematical Model of Zoonotic NIPAH virus in South-East Asia region
 
Durgesh Sinha, Temple University/ Strayer University, USA
 
Title: EFdA: An Extremely Excellent Anti-HIV Modified Nucleoside
 
Hiroshi Ohrui, Yokohama University of Pharmacy, Japan
 
The proceedings of the conference were embarked with an opening ceremony followed by Special sessions and a series of Lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talks were:
 
Keynote forum:
 
Hiroshi Ohrui, Yokohama University of Pharmacy, Japan

To Collaborate Scientific Professionals around the World

Conference Date March 22-23, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Day 1 Day 2

Supported By

Journal of Infectious Diseases and Diagnosis Journal of Bacteriology & Parasitology Journal of Infectious Diseases & Preventive Medicine Open Access Journal of Hematology & Thromboembolic Diseases

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner